Cargando…

The Absence of STING Ameliorates Non-Alcoholic Fatty Liver Disease and Reforms Gut Bacterial Community

Non-alcoholic fatty liver disease (NAFLD) is one of the primary causes of cirrhosis and a major risk factor for hepatocellular carcinoma and liver-related death. It has been correlated with changes in the gut microbiota, which promote its development by regulating insulin resistance, bile acid and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qiang, Chen, Qiongyun, Yan, Changsheng, Niu, Chunyan, Zhou, Jingping, Liu, Jingjing, Song, Yang, Zhou, Fei, Fan, Yanyun, Ren, Jianlin, Xu, Hongzhi, Zhang, Bangzhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279660/ https://www.ncbi.nlm.nih.gov/pubmed/35844603 http://dx.doi.org/10.3389/fimmu.2022.931176

Ejemplares similares

Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis
por: Chen, Qiongyun, et al.
Publicado: (2023)

Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation
por: Chen, Qiongyun, et al.
Publicado: (2023)

Leveraging Fecal Bacterial Survey Data to Predict Colorectal Tumors
por: Zhang, Bangzhou, et al.
Publicado: (2019)

Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease
por: Chen, Zhangran, et al.
Publicado: (2020)

Appendectomy Is Associated With Alteration of Human Gut Bacterial and Fungal Communities
por: Cai, Shuntian, et al.
Publicado: (2021)

Long intergenic non-protein-coding RNA 01446 facilitates the proliferation and metastasis of gastric cancer cells through interacting with the histone lysine-specific demethylase LSD1
por: Lian, Yifan, et al.
Publicado: (2020)

Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application Potential
por: Que, Yanyan, et al.
Publicado: (2021)

Mini review: STING activation during non-alcoholic fatty liver disease
por: Li, Honggui, et al.
Publicado: (2023)

Serum Metabolomics Analysis in Wasp Sting Patients
por: Yang, Xianyi, et al.
Publicado: (2018)

Biopanning of allergens from wasp sting patients
por: Chai, Lin, et al.
Publicado: (2018)

Corneal bee sting: improvement in the acute stage in the absence of treatment
por: Chen, Michael Carl, et al.
Publicado: (2020)

The STING in Non-Alcoholic Fatty Liver Diseases: Potential Therapeutic Targets in Inflammation-Carcinogenesis Pathway
por: Lv, Juan, et al.
Publicado: (2022)

REFORMATION OF NUCLEOLUS-LIKE BODIES IN THE ABSENCE OF POSTMITOTIC RNA SYNTHESIS
por: Stevens, A. R., et al.
Publicado: (1971)

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2021)

Saturated fatty acids dampen the immunogenicity of cancer by suppressing STING
por: Heath, Blake R., et al.
Publicado: (2023)

Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
por: Ni, Yiming, et al.
Publicado: (2023)

Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
por: Ko, Masayoshi, et al.
Publicado: (2023)

Alcohol industry strategies to influence the reform of the Finnish Alcohol Law
por: Sama, Thomas Babila, et al.
Publicado: (2019)

Alcohol-dependent downregulation of apolipoprotein H exacerbates fatty liver and gut microbiota dysbiosis in mice
por: Liu, Yaming, et al.
Publicado: (2022)

Long non-coding RNA ERICH3-AS1 is an unfavorable prognostic factor for gastric cancer
por: Chen, Qiongyun, et al.
Publicado: (2020)

Lithium ameliorates Niemann-Pick C1 disease phenotypes by impeding STING/SREBP2 activation
por: Han, Shiqian, et al.
Publicado: (2023)

Vildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease
por: Hussain, Mazhar, et al.
Publicado: (2016)

Ipragliflozin Ameliorates Liver Damage in Non-alcoholic Fatty Liver Disease
por: Miyake, Teruki, et al.
Publicado: (2018)

REFORMATION OF NUCLEOLI AFTER ETHIONE-INDUCED FRAGMENTATION IN THE ABSENCE OF SIGNIFICANT PROTEIN SYNTHESIS
por: Shinozuka, Hisashi, et al.
Publicado: (1969)

Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine
por: Zhou, Zhijia, et al.
Publicado: (2022)

The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in rats
por: Dai, Yufan, et al.
Publicado: (2022)

Butyrate ameliorates alcoholic fatty liver disease via reducing endotoxemia and inhibiting liver gasdermin D-mediated pyroptosis
por: Zhang, Ting, et al.
Publicado: (2021)

Diosgenin Ameliorates Non-alcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Related Lipid/Amino Acid Metabolism in High Fat Diet-Fed Rats
por: Zhou, Yuan, et al.
Publicado: (2022)

Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease
por: Wang, Huan, et al.
Publicado: (2023)

Electrification of a Milstein-type catalyst for alcohol reformation
por: Tocqueville, Damien, et al.
Publicado: (2022)

Seabuckthorn polysaccharide combined with astragalus polysaccharide ameliorate alcoholic fatty liver by regulating intestinal flora
por: Liu, Jiayue, et al.
Publicado: (2022)

STING modulators: Predictive significance in drug discovery
por: Cui, Xiangling, et al.
Publicado: (2019)

Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease
por: Bertran, Laia, et al.
Publicado: (2023)

Improving the ameliorative effects of berberine and curcumin combination via dextran-coated bilosomes on non-alcohol fatty liver disease in mice
por: Chen, Yi, et al.
Publicado: (2021)

Probiotic Engineering and Targeted Sonoimmuno‐Therapy Augmented by STING Agonist
por: Lu, Dan, et al.
Publicado: (2022)

Polyunsaturated fatty acids ameliorate aging via redox-telomere-antioncogene axis
por: Chen, Jingnan, et al.
Publicado: (2016)

Water Extract of Curcuma longa L. Ameliorates Non-Alcoholic Fatty Liver Disease
por: Mun, Jeongeun, et al.
Publicado: (2019)

Sting /
por: Leduc, Jean-Marie
Publicado: (1992)

Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease
por: Zhao, Ruifang, et al.
Publicado: (2020)

Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation
por: Ye, Jia-Hung, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_395113uctig9gnusfa5k3hi375